Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

Status:	Recruiting
Conditions:	Atrial Fibrillation, Other Indications, Cardiology
Therapuetic Areas:	Cardiology / Vascular Diseases, Other
Healthy:	No
Age Range:	20 - 90
Updated:	9/22/2018
Start Date:	August 2000
End Date:	August 2030

This study aims to identify genetic causes of adverse events after cardiac surgery, such as
atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.

Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute
are eligible to participate.

This study aims to identify genetic causes of adverse events after cardiac surgery, such as
atrial fibrillation, myocardial infarction, renal dysfunction and heart failure.

Inclusion Criteria:

- Undergoing heart surgery

- Willing to provide consent

Exclusion Criteria:

- Enrolled in a concurrent drug or device trial that precludes concurrent enrollment

We found this trial at

sites

Brigham and Women's Hosp

75 Francis street
Boston, Massachusetts 02115

(617) 732-5500